 | 8HT | Name: | ~{N}-[(1~{S})-1-(1~{H}-benzimidazol-2-yl)-4-(2-fluoranylethanimidoylamino)butyl]-4-phenyl-benzamide | Formula: | C26 H26 F N5 O | SMILES: | FCC(=N)NCCC[CH](NC(=O)c1ccc(cc1)c2ccccc2)c3[nH]c4ccccc4n3 | InChi: | InChI=1S/C26H26FN5O/c27-17-24(28)29-16-6-11-23(25-30-21-9-4-5-10-22(21)31-25)32-26(33)20-14-12-19(13-15-20)18-7-2-1-3-8-18/h1-5,7-10,12-15,23H,6,11,16-17H2,(H2,28,29)(H,30,31)(H,32,33)/t23-/m0/s1 | Definition date: | 2017-02-07 | Last modified: | 2024-09-27 | Release date: | 2017-05-24 | Identifier: | ~{N}-[(1~{S})-1-(1~{H}-benzimidazol-2-yl)-4-(2-fluoranylethanimidoylamino)butyl]-4-phenyl-benzamide |
|
 | LX5 | Name: | [(1~{S},2~{S},3~{S},4~{S})-2-(hydroxymethyl)-3,4-bis(oxidanyl)cyclopentyl] hydrogen sulfate | Formula: | C6 H12 O7 S | SMILES: | OC[CH]1[CH](O)[CH](O)C[CH]1O[S](O)(=O)=O | InChi: | InChI=1S/C6H12O7S/c7-2-3-5(13-14(10,11)12)1-4(8)6(3)9/h3-9H,1-2H2,(H,10,11,12)/t3-,4+,5+,6+/m1/s1 | Definition date: | 2019-09-26 | Last modified: | 2024-09-27 | Release date: | 2020-02-26 | Identifier: | [(1~{S},2~{S},3~{S},4~{S})-2-(hydroxymethyl)-3,4-bis(oxidanyl)cyclopentyl] hydrogen sulfate |
|
 | 8I0 | Name: | (1R,2S,5S)-N-{(2S,3R)-4-(benzylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide | Formula: | C34 H52 N6 O6 | SMILES: | CC1(C)C2C(C(=O)NC(CC3CCNC3=O)C(O)C(=O)NCc3ccccc3)N(CC21)C(=O)C(NC(=O)NC(C)(C)C)C(C)(C)C | InChi: | InChI=1S/C34H52N6O6/c1-32(2,3)26(38-31(46)39-33(4,5)6)30(45)40-18-21-23(34(21,7)8)24(40)28(43)37-22(16-20-14-15-35-27(20)42)25(41)29(44)36-17-19-12-10-9-11-13-19/h9-13,20-26,41H,14-18H2,1-8H3,(H,35,42)(H,36,44)(H,37,43)(H2,38,39,46)/t20-,21-,22-,23-,24-,25+,26+/m0/s1 | Definition date: | 2021-09-16 | Last modified: | 2024-09-27 | Release date: | 2022-07-27 | Identifier: | (1R,2S,5S)-N-{(2S,3R)-4-(benzylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide |
|
 | 8I4 | Name: | (2R,3S,5R,6R)-2,3,4,5,6-pentakis(oxidanyl)cyclohexane-1-carboxylic acid | Formula: | C7 H12 O7 | SMILES: | O[CH]1[CH](O)[CH](O)[CH]([CH](O)[CH]1O)C(O)=O | InChi: | InChI=1S/C7H12O7/c8-2-1(7(13)14)3(9)5(11)6(12)4(2)10/h1-6,8-12H,(H,13,14)/t1-,2-,3?,4+,5+,6-/m1/s1 | Synonyms: | (2R)-5-[(E)-2-(2,4-dinitrophenyl)ethenyl]-2-[(1R)-2-oxidanyl-2-oxidanylidene-1-(2-thiophen-2-ylethanoylamino)ethyl]-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid | Definition date: | 2021-09-16 | Last modified: | 2024-09-27 | Release date: | 2022-08-03 | Identifier: | (2~{R},3~{S},5~{S},6~{S})-2,3,4,5,6-pentakis(oxidanyl)cyclohexane-1-carboxylic acid |
|
 | LXB | Name: | 2-acetamido-2-deoxy-beta-D-gulopyranose | Formula: | C8 H15 N O6 | SMILES: | O=C(NC1C(O)C(O)C(OC1O)CO)C | InChi: | InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6+,7+,8-/m1/s1 | Synonyms: | N-acetyl-beta-D-gulosamine | Definition date: | 2008-07-23 | Last modified: | 2024-09-27 | Identifier: | 2-(acetylamino)-2-deoxy-beta-D-gulopyranose |
|
 | 8I7 | Name: | (1R,2S,5S)-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(3-methylbutanoyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide | Formula: | C26 H44 N4 O5 | SMILES: | CC1(C)C2C(C(=O)NC(CC3CCNC3=O)CO)N(CC21)C(=O)C(NC(=O)CC(C)C)C(C)(C)C | InChi: | InChI=1S/C26H44N4O5/c1-14(2)10-18(32)29-21(25(3,4)5)24(35)30-12-17-19(26(17,6)7)20(30)23(34)28-16(13-31)11-15-8-9-27-22(15)33/h14-17,19-21,31H,8-13H2,1-7H3,(H,27,33)(H,28,34)(H,29,32)/t15-,16-,17-,19-,20-,21+/m0/s1 | Definition date: | 2021-09-16 | Last modified: | 2024-09-27 | Release date: | 2022-07-27 | Identifier: | (1R,2S,5S)-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(3-methylbutanoyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide |
|
 | LXD | Name: | (4~{S})-2-azanyl-4-[3-[6-[(2~{S})-2,4-dimethylpiperazin-1-yl]-4-(4-prop-2-enoylpiperazin-1-yl)pyridin-2-yl]-1,2,4-oxadiazol-5-yl]-4-methyl-6,7-dihydro-5~{H}-1-benzothiophene-3-carbonitrile | Formula: | C30 H37 N9 O2 S | SMILES: | C[CH]1CN(C)CCN1c2cc(cc(n2)c3noc(n3)[C]4(C)CCCc5sc(N)c(C#N)c45)N6CCN(CC6)C(=O)C=C | InChi: | InChI=1S/C30H37N9O2S/c1-5-25(40)38-12-10-37(11-13-38)20-15-22(33-24(16-20)39-14-9-36(4)18-19(39)2)28-34-29(41-35-28)30(3)8-6-7-23-26(30)21(17-31)27(32)42-23/h5,15-16,19H,1,6-14,18,32H2,2-4H3/t19-,30-/m0/s1 | Definition date: | 2022-07-18 | Last modified: | 2024-09-27 | Release date: | 2022-11-09 | Identifier: | (4~{S})-2-azanyl-4-[3-[6-[(2~{S})-2,4-dimethylpiperazin-1-yl]-4-(4-prop-2-enoylpiperazin-1-yl)pyridin-2-yl]-1,2,4-oxadiazol-5-yl]-4-methyl-6,7-dihydro-5~{H}-1-benzothiophene-3-carbonitrile |
|
 | LXE | Name: | [(1~{S},2~{S},3~{S},4~{S})-2-(hydroxymethyl)-3,4-bis(oxidanyl)cyclopentyl]azanium | Formula: | C6 H14 N O3 | SMILES: | [NH3+][CH]1C[CH](O)[CH](O)[CH]1CO | InChi: | InChI=1S/C6H13NO3/c7-4-1-5(9)6(10)3(4)2-8/h3-6,8-10H,1-2,7H2/p+1/t3-,4+,5+,6+/m1/s1 | Definition date: | 2019-09-27 | Last modified: | 2024-09-27 | Release date: | 2020-02-26 | Identifier: | [(1~{S},2~{S},3~{S},4~{S})-2-(hydroxymethyl)-3,4-bis(oxidanyl)cyclopentyl]azanium |
|
 | LXF | Name: | N-{4-[(2-phenylethyl)sulfamoyl]-1,3-benzothiazol-2-yl}acetamide | Formula: | C17 H17 N3 O3 S2 | SMILES: | O=S(=O)(NCCc1ccccc1)c1cccc2sc(nc12)NC(C)=O | InChi: | InChI=1S/C17H17N3O3S2/c1-12(21)19-17-20-16-14(24-17)8-5-9-15(16)25(22,23)18-11-10-13-6-3-2-4-7-13/h2-9,18H,10-11H2,1H3,(H,19,20,21) | Definition date: | 2023-08-15 | Last modified: | 2024-09-27 | Release date: | 2023-11-08 | Identifier: | N-{4-[(2-phenylethyl)sulfamoyl]-1,3-benzothiazol-2-yl}acetamide |
|
 | LXO | Name: | 4-(pyridin-4-ylamino)butanoic acid | Formula: | C9 H12 N2 O2 | SMILES: | OC(=O)CCCNc1ccncc1 | InChi: | InChI=1S/C9H12N2O2/c12-9(13)2-1-5-11-8-3-6-10-7-4-8/h3-4,6-7H,1-2,5H2,(H,10,11)(H,12,13) | Definition date: | 2022-12-16 | Last modified: | 2024-09-27 | Release date: | 2023-12-13 | Identifier: | 4-(pyridin-4-ylamino)butanoic acid |
|
 | LXV | Name: | 2,5-dibromo-N-{(3R,5S)-1-[(Z)-iminomethyl]-5-methylpyrrolidin-3-yl}benzenesulfonamide | Formula: | C12 H15 Br2 N3 O2 S | SMILES: | Brc1cc(c(Br)cc1)S(=O)(=O)NC2CC(N(C=[N@H])C2)C | InChi: | InChI=1S/C12H15Br2N3O2S/c1-8-4-10(6-17(8)7-15)16-20(18,19)12-5-9(13)2-3-11(12)14/h2-3,5,7-8,10,15-16H,4,6H2,1H3/b15-7+/t8-,10+/m0/s1 | Definition date: | 2010-11-02 | Last modified: | 2024-09-27 | Identifier: | 2,5-dibromo-N-{(3R,5S)-1-[(Z)-iminomethyl]-5-methylpyrrolidin-3-yl}benzenesulfonamide |
|
 | LXZ | Name: | 2-acetamido-2-deoxy-alpha-D-idopyranose | Formula: | C8 H15 N O6 | SMILES: | O=C(NC1C(O)C(O)C(OC1O)CO)C | InChi: | InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5+,6+,7+,8+/m1/s1 | Synonyms: | N-acetyl-alpha-D-idosamine | Definition date: | 2008-07-09 | Last modified: | 2024-09-27 | Identifier: | 2-(acetylamino)-2-deoxy-alpha-D-idopyranose |
|
 | LYF | Name: | (2E,4S)-2-{[(5S)-5-amino-5-carboxypentyl]imino}-4-hydroxyheptanedioic acid | Formula: | C13 H22 N2 O7 | SMILES: | O=C(O)C(N)CCCC/N=C(/C(=O)O)CC(O)CCC(=O)O | InChi: | InChI=1S/C13H22N2O7/c14-9(12(19)20)3-1-2-6-15-10(13(21)22)7-8(16)4-5-11(17)18/h8-9,16H,1-7,14H2,(H,17,18)(H,19,20)(H,21,22)/b15-10+/t8-,9-/m0/s1 | Definition date: | 2011-10-25 | Last modified: | 2024-09-27 | Identifier: | (2E,4S)-2-{[(5S)-5-amino-5-carboxypentyl]imino}-4-hydroxyheptanedioic acid |
|
 | 8JB | Name: | (2~{R})-2-azanyl-3-[[(5~{S})-5-[(1~{S})-1-azanyl-2-oxidanyl-2-oxidanylidene-ethyl]-4,5-dihydro-1,2-oxazol-3-yl]sulfanyl]propanoic acid | Formula: | C8 H13 N3 O5 S | SMILES: | N[CH](CSC1=NO[CH](C1)[CH](N)C(O)=O)C(O)=O | InChi: | InChI=1S/C8H13N3O5S/c9-3(7(12)13)2-17-5-1-4(16-11-5)6(10)8(14)15/h3-4,6H,1-2,9-10H2,(H,12,13)(H,14,15)/t3-,4-,6-/m0/s1 | Definition date: | 2017-02-08 | Last modified: | 2024-09-27 | Release date: | 2017-04-05 | Identifier: | (2~{R})-2-azanyl-3-[[(5~{S})-5-[(1~{S})-1-azanyl-2-oxidanyl-2-oxidanylidene-ethyl]-4,5-dihydro-1,2-oxazol-3-yl]sulfanyl]propanoic acid |
|
 | 8JC | Name: | N-[3-[[2-[[4-(4-ethanoylpiperazin-1-yl)-2-methoxy-phenyl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide | Formula: | C27 H28 F3 N7 O3 | SMILES: | COc1cc(ccc1Nc2ncc(c(Nc3cccc(NC(=O)C=C)c3)n2)C(F)(F)F)N4CCN(CC4)C(C)=O | InChi: | InChI=1S/C27H28F3N7O3/c1-4-24(39)32-18-6-5-7-19(14-18)33-25-21(27(28,29)30)16-31-26(35-25)34-22-9-8-20(15-23(22)40-3)37-12-10-36(11-13-37)17(2)38/h4-9,14-16H,1,10-13H2,2-3H3,(H,32,39)(H2,31,33,34,35) | Definition date: | 2017-07-14 | Last modified: | 2024-09-27 | Release date: | 2017-12-13 | Identifier: | ~{N}-[3-[[2-[[4-(4-ethanoylpiperazin-1-yl)-2-methoxy-phenyl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide |
|
 | LYH | Name: | 3,4 ENE-LYSINE | Formula: | C6 H12 N2 O2 | SMILES: | O=C(O)C(/C=C/CCN)N | InChi: | InChI=1S/C6H12N2O2/c7-4-2-1-3-5(8)6(9)10/h1,3,5H,2,4,7-8H2,(H,9,10)/b3-1+/t5-/m0/s1 | Synonyms: | (2S,3E)-2,6-DIAMINOHEX-3-ENOIC ACID | Definition date: | 2011-03-14 | Last modified: | 2024-09-27 | Release date: | 2012-08-24 | Identifier: | (2S,3E)-2,6-diaminohex-3-enoic acid |
|
 | LYJ | Name: | (2S)-2,6-diaminohexan-1-ol | Formula: | C6 H16 N2 O | SMILES: | OCC(N)CCCCN | InChi: | InChI=1S/C6H16N2O/c7-4-2-1-3-6(8)5-9/h6,9H,1-5,7-8H2/t6-/m0/s1 | Definition date: | 2012-01-18 | Last modified: | 2024-09-27 | Identifier: | (2S)-2,6-diaminohexan-1-ol |
|
 | LYK | Name: | (2S)-2,6-diaminohexane-1,1-diol | Formula: | C6 H16 N2 O2 | SMILES: | OC(O)C(N)CCCCN | InChi: | InChI=1S/C6H16N2O2/c7-4-2-1-3-5(8)6(9)10/h5-6,9-10H,1-4,7-8H2/t5-/m0/s1 | Definition date: | 2010-10-08 | Last modified: | 2024-09-27 | Identifier: | (2S)-2,6-diaminohexane-1,1-diol |
|
 | LYN | Name: | 2,6-DIAMINO-HEXANOIC ACID AMIDE | Formula: | C6 H16 N3 O | SMILES: | O=C(N)C(N)CCCC[NH3+] | InChi: | InChI=1S/C6H15N3O/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H2,9,10)/p+1/t5-/m0/s1 | Definition date: | 2000-11-10 | Last modified: | 2024-09-27 | Identifier: | 6-ammonio-L-norleucinamide |
|
 | LYO | Name: | 4-HYDROXY-LYSINE | Formula: | C6 H14 N2 O3 | SMILES: | O=C(O)C(N)CC(O)CCN | InChi: | InChI=1S/C6H14N2O3/c7-2-1-4(9)3-5(8)6(10)11/h4-5,9H,1-3,7-8H2,(H,10,11)/t4-,5-/m0/s1 | Definition date: | 2011-03-30 | Last modified: | 2024-09-27 | Release date: | 2012-10-19 | Identifier: | (4S)-4-hydroxy-L-lysine |
|
 | LYP | Name: | N~6~-METHYL-N~6~-PROPYL-L-LYSINE | Formula: | C10 H22 N2 O2 | SMILES: | O=C(O)C(N)CCCCN(CCC)C | InChi: | InChI=1S/C10H22N2O2/c1-3-7-12(2)8-5-4-6-9(11)10(13)14/h9H,3-8,11H2,1-2H3,(H,13,14)/t9-/m0/s1 | Definition date: | 2007-03-28 | Last modified: | 2024-09-27 | Identifier: | N~6~-methyl-N~6~-propyl-L-lysine |
|
 | LYR | Name: | N~6~-[(2Z,4E,6E,8E)-3,7-DIMETHYL-9-(2,6,6-TRIMETHYLCYCLOHEX-1-EN-1-YL)NONA-2,4,6,8-TETRAENYL]LYSINE | Formula: | C26 H42 N2 O2 | SMILES: | O=C(O)C(N)CCCCNC/C=C(/C=CC=C(C=CC1=C(CCCC1(C)C)C)C)C | InChi: | InChI=1S/C26H42N2O2/c1-20(14-15-23-22(3)12-9-17-26(23,4)5)10-8-11-21(2)16-19-28-18-7-6-13-24(27)25(29)30/h8,10-11,14-16,24,28H,6-7,9,12-13,17-19,27H2,1-5H3,(H,29,30)/b11-8-,15-14+,20-10+,21-16+/t24-/m0/s1 | Definition date: | 2005-03-17 | Last modified: | 2024-09-27 | Identifier: | N~6~-[(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl]-L-lysine |
|
 | LYS | Name: | LYSINE | Formula: | C6 H15 N2 O2 | SMILES: | O=C(O)C(N)CCCC[NH3+] | InChi: | InChI=1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/p+1/t5-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 6-ammonio-L-norleucine |
|
 | LYT | Name: | BUTYLAMINE | Formula: | C4 H11 N | SMILES: | NCCCC | InChi: | InChI=1S/C4H11N/c1-2-3-4-5/h2-5H2,1H3 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | butan-1-amine |
|
 | LYV | Name: | O-phosphono-L-seryl-N-[(3S)-3-amino-3-carboxypropyl]glycinamide | Formula: | C9 H19 N4 O8 P | SMILES: | O=P(OCC(C(=O)NCC(=O)NCCC(C(=O)O)N)N)(O)O | InChi: | InChI=1S/C9H19N4O8P/c10-5(9(16)17)1-2-12-7(14)3-13-8(15)6(11)4-21-22(18,19)20/h5-6H,1-4,10-11H2,(H,12,14)(H,13,15)(H,16,17)(H2,18,19,20)/t5-,6-/m0/s1 | Definition date: | 2013-12-06 | Last modified: | 2024-09-27 | Release date: | 2014-12-03 | Identifier: | O-phosphono-L-seryl-N-[(3S)-3-amino-3-carboxypropyl]glycinamide |
|